Mark Sommerville Email

Staff Scientist . Pearl Therapeutics

Current Roles

Employees:
44
Revenue:
$4.4M
About
Pearl Therapeutics is developing a pipeline of advanced respiratory products that will offer patients and their healthcare providers a choice of formulations and dosage strengths better suited to their needs. Pearl's products will afford multiple health benefits compared to current treatment options and will be available in familiar and widely used dosage forms to enhance compliance. The company has licensed advanced particle technology from Nektar Therapeutics and is developing it further for application in selected fields.
Pearl Therapeutics Address
280 Headquarters Plaza
Morristown, NJ
United States
Pearl Therapeutics Email

Past Companies

AstraZeneca (formerly Pearl Therapeutics)Senior Principal Scientist
Pearl TherapeuticsStaff Scientist
GSKDevelopment Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.